3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
2
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
98
Stomach Neoplasms
50
Rectal Neoplasms
45
Pancreatic Neoplasms
45
Colonic Neoplasms
36
Esophageal Neoplasms
34
Neoplasms
30
Neoplasm Metastasis
28
Squamous Cell Carcinoma of Head and Neck
27
Head and Neck Neoplasms
24
Breast Neoplasms
21
Adenocarcinoma Of Esophagus
20
Parkinson Disease 4, Autosomal Dominant Lewy Body
12
Adenocarcinoma
9
Anus Neoplasms
8
Esophageal Squamous Cell Carcinoma
7
Carcinoma, Squamous Cell
7
Carcinoma
7
Cholangiocarcinoma
6
Liver Neoplasms
5
Gallbladder Neoplasms
5
Bile Duct Neoplasms
5
Urinary Bladder Neoplasms
4
Pancreatic Adenocarcinoma
4
Gastrointestinal Neoplasms
4
Carcinoma, Hepatocellular
4
Skin Neoplasms
3
Sarcoma
3
Peritoneal Neoplasms
3
Laryngeal Neoplasms
3
Interventions
human papillomavirus vaccine, L1 type 16, 18
30
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
20
Papillomavirus Vaccines
9
Radiotherapy, Intensity-Modulated
4
Cisplatin
4
Blood Specimen Collection
4
fludarabine
3
Vaccines, Synthetic
3
Engerix-B
3
Cyclophosphamide
3
halofantrine
2
fludarabine phosphate
2
aldesleukin
2
Watchful Waiting
2
Vaccines
2
Patient Navigation
2
Paclitaxel
2
Light Coagulation
2
Interleukin-2
2
Imiquimod
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Hepatitis A Vaccines
2
Fluorouracil
2
Electrocoagulation
2
Cetuximab
2
Carboplatin
2
Albumin-Bound Paclitaxel
2
utomilumab
1
polyphenon E
1
infigratinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Has results
×
Papillomavirus Infections
×
Fluorouracil
×
Clear all
NCT02258659
2024-09-24
OPTIMA
University of Chicago
Phase 2
Completed
62 enrolled
13 charts
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts